Jazz Pharmaceuticals(JAZZ) - 2025 Q4 - Earnings Call Transcript

Jazz Pharmaceuticals (NasdaqGS:JAZZ) Q4 2025 Earnings call February 24, 2026 04:30 PM ET Company ParticipantsJohn Bluth - Head of Investor RelationsMichael Riad - VPMohit Bansal - Managing DirectorPhil Johnson - EVP and CFORenee Gala - President and CEORob Iannone - EVP of Research and DevelopmentSam Pearce - Chief Commercial OfficerNone - ShareholderConference Call ParticipantsAmi Fadia - Senior AnalystBrian Skorney - Senior Research AnalystDavid Amsellem - Managing Director and Senior Research AnalystDavi ...